Homology Medicines, Inc.
USD0.93
+0.01 (+0.77%)
CEO
Paul Alloway
IPO Date
2018-03-28
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.92
Prev. Close
$0.93
Day Low
$0.90
Day High
$0.97
52W Low
$0.90
52W High
$26.64
Market Cap
$0.00B
Volume
0.40M
| -0.9 |
| 31 Dec 2023 | FY | 100.0% | 808.0% | 29.4% | -114.2% | -0.28 | 2.04 | -0.7 |
| 31 Dec 2022 | FY | 100.0% | -643.6% | -24.1% | -69.3% | 0.25 | 0.81 | -1.7 |
| 31 Dec 2021 | FY | 71.9% | -281.9% | -56.4% | -45.2% | 0.14 | 11.14 | -2.1 |
| 31 Dec 2020 | FY | 100.0% | -4762.9% | -65.7% | -48.8% | 0.08 | 9.69 | -4.0 |
| 31 Dec 2019 | FY | 100.0% | -6237.5% | -40.2% | -33.5% | 0.00 | 21.54 | -8.4 |
| 31 Dec 2018 | FY | 100.0% | -1044.3% | -28.3% | -21.5% | 0.00 | 9.84 | -11.5 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -30.5% | -21.8% | 0.00 | 14.85 | -23.3 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -107.3% | -56.6% | 0.00 | 1.88 | -86.8 |
| 0.2 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | 40.1% | -12.8% | -0.62 | 4.57 | -0.8 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | 77.6% | -14.4% | -1.53 | 5.06 | -0.5 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | 274.8% | -14.0% | -4.68 | 4.71 | -0.5 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -250.0% | -15.4% | 3.33 | 4.97 | -0.7 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -96.2% | -16.8% | 1.06 | 6.53 | -7.7 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -50.7% | -13.7% | 0.59 | 6.49 | -3.3 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | 2.1% | 0.7% | 0.41 | 4.19 | 52.2 |
| 31 Dec 2023 | Q4 | 100.0% | 184.6% | 14.8% | -57.5% | -0.28 | 2.04 | -0.3 |